T-cell masthead image

Publications

Publication

Soligenix on IDR technology and SGX942

Dr. Oreola Donini, Chief Scientific Officer of Soligenix, Inc. recently discussed the IDR technology and SGX942 with two publications.
Publication

Journal of Biotechnology – A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy

The publication of data demonstrating the mechanism and broad-spectrum activity of dusquetide in preclinical bacterial infection models
Publication

NJBIZ – Impacting the world: Soligenix discovery could dramatically change vaccinations

Dr. Christopher J. Schaber, President & CEO discusses ThermoVax™ technology and the vaccine market
Publication

Drug Discovery News: On The Front Lines of Biodefense

Q&A with Dr. Christopher J. Schaber, President & CEO
Publication

International Innovation – Bullseye: Targeting Cancer with Selective Innovations, Issue 190

Drs. Schaber and Straube Discuss Treatment of Cutaneous T-Cell Lymphoma in Recent Publication